Body mass, chronic heart failure, surgery and survival

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 261-264

  Clark, Andrew L ^a   Anker, Stefan D ^b  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cardiac cachexia; heart failure; mechanical support; outcome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC SYSTEM; ARTICLE; BODY MASS; CACHEXIA; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; WEIGHT REDUCTION;

BODY MASS INDEX; CACHEXIA; CHRONIC DISEASE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; IMMUNE SYSTEM; PATIENT SELECTION; PROGNOSIS; SURVIVAL RATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 77349105110     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.004     Document Type: Article

References (41)

1. Kalantar-Zadeh K., Block G., Humphreys M.H., et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
2. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
3. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
4. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
5. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
6. Horwich T.B., Hamilton M.A., Maclellan W.R., et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
7. Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
8. Kenchaiah S., Pocock S.J., Wang D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation 116 (2007) 627-636
9. Rossner S., Taylor C.L., Byington R.P., et al. Long term propranolol treatment and changes in body weight after myocardial infarction. BMJ 300 (1990) 902-903
10. Riley M., Elborn J.S., McKane W.R., et al. Resting energy expenditure in chronic cardiac failure. Clin Sci (Lond) 80 (1991) 633-639
11. Poehlman E.T., Scheffers J., Gottlieb S.S., et al. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 121 (1994) 860-862
12. Witte K.K., Ford S.J., Preston T., et al. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol 129 (2008) 363-367
13. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
14. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
15. Berry C., and Clark A.L. Catabolism in chronic heart failure. Eur Heart J 21 (2000) 521-532
16. Torti F.M., Dieckman B., Beutler B.A., et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229 (1985) 867-869
17. Chung E.S., Packer M., Lo K.H., et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107 (2003) 3133-3140
18. Mann D.L., McMurray J.J., Packer M., et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109 (2004) 1594-1602
19. Hyltander A., Daneryd P., Sandstrom R., et al. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. Eur J Cancer 36 (2000) 330-334
20. Drott C., Persson H., and Lundholm K. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with or without cancer. Clin Physiol 9 (1989) 427-439
21. Bessey P.Q., Watters J.M., Aoki T.T., et al. Combined hormonal infusion simulates the metabolic response to injury. Ann Surg 200 (1984) 264-281
22. Watters J.M., Bessey P.Q., Dinarello C.A., et al. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg 121 (1986) 179-190
23. Hryniewicz K., Androne A.S., Hudraihed A., et al. Partial reversal of cachexia by β-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Failure 9 (2003) 464-468
24. Podbregar M., and Voga G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Card Fail 8 (2002) 369-378
25. Tan L.B., Bruniston J.G., Clark W.A., et al. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: towards a new bioassay for beta-blockers. J Cardiovasc Pharmacol 41 (2003) 518-525
26. Burniston J.G., Ng Y., Clark W.A., et al. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 93 (2002) 1824-1832
27. Ng Y., Goldspink D.F., Burniston J.G., et al. Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol 86 (2002) 299-309
28. Donahoo W.T., Jensen D.R., Yost T.J., et al. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 82 (1997) 4139-4143
29. Deibert D.C., and DeFronzo R.A. Epinephrine-induced insulin resistance in man. J Clin Invest 65 (1980) 717-721
30. Severn A., Rapson N.T., Hunter C.A., et al. Regulation of tumour necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148 (1992) 3441-3445
31. Herndon D.N., Hart D.W., Wolf S.E., et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 (2001) 1223-1229
32. Abel R.M., Fischer J.E., Buckley M.J., et al. Malnutrition in cardiac surgical patients: results of a prospective, randomized evaluation of early postoperative parenteral nutrition. Arch Surg 111 (1976) 45-50
33. Rich M.W., Keller A.J., Schechtman K.B., et al. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol 63 (1989) 714-718
34. Rady M.Y., Ryan T., and Starr N.J. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. J Parenter Enteral Nutr 21 (1997) 81-90
35. Carrier M., Rivard M., Latter D., et al. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. Can J Cardiol 14 (1998) 703-707
36. Lietz K., John R., Burke E.A., et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 72 (2001) 277-283
37. Grady K.L., White-Williams C., Naftel D., et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality?. A multi-institutional study of preoperative weight-height indices. J Heart Lung Transplant 18 (1999) 750-763
38. Clark A.L., Knosalla C., Birks E., et al. Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. Eur J Heart Fail 9 (2007) 839-844
39. National Center for Health Statistics. Weight by height and age for adults 18-74 years: United States 1971-1974. Vital and health statistics (1979), Government Printing Office, Washington, DC Series 11. No. 208. DHEW Publication PHS 79-1656
40. Mano A., Fujita K., Uenomachi K., et al. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 28 (2009) 428-433
41. Clark A.L., Loebe M., Potapov E.V., et al. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J 22 (2001) 2275-2283